Extragastric manifestations of helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases

World Journal of Hepatology

Volumn 7, Issue 30, 2015, Pages 2968-2979

  Elizabeth MA, Rabelo Gonçalves ^a   Roesler, Bruna M ^a   Zeitune, José MR ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cirrhosis; Diabetes mellitus; Fibrosis; Helicobacter pylori; Hepatic encephalopathy; Hepatocellular carcinoma; Metabolic syndrome; Nonalcoholic fatty liver disease; Pancreatic cancer; Pancreatitis

Indexed keywords

EID: 84952793348     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i30.2968     Document Type: Article

References (155)

1. Moodley Y, Linz B, Bond RP, Nieuwoudt M, Soodyall H, Schlebusch CM, Bernhöft S, Hale J, Suerbaum S, Mugisha L, van der Merwe SW, Achtman M. Age of the association between Helicobacter pylori and man. PLoS Pathog 2012; 8: e1002693 [PMID: 22589724 DOI: 10.1371/journal.ppat.1002693]
2. Roubaud Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter 2013; 18 Suppl 1: 44-51 [PMID: 24011245 DOI: 10.1111/hel.12077]
3. Mishra S. Is Helicobacter pylori good or bad? Eur J Clin Microbiol Infect Dis 2013; 32: 301-304 [PMID: 23132690 DOI: 10.1007/ s10096-012-1773-9]
4. Makola D, Peura DA, Crowe SE. Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 2007; 41: 548-558 [PMID: 17577110]
5. Franceschi F, Gasbarrini A. Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol 2007; 21: 325-334 [PMID: 17382280]
6. Roubaud-Baudron C, Krolak-Salmon P, Quadrio I, Mégraud F, Salles N. Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results. Neurobiol Aging 2012; 33: 1009.e11-1009.e19 [PMID: 22133280 DOI: 10.1016/j.neurobiolaging.2011.10.021]
7. Venerito M, Selgrad M, Malfertheiner P. Helicobacter pylori: gastric cancer and extragastric malignancies-clinical aspects. Helicobacter 2013; 18 Suppl 1: 39-43 [PMID: 24011244 DOI: 10.1111/hel.12078]
8. Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 1996; 34: 685-686 [PMID: 8601663]
9. Zentilin P, Seriolo B, Dulbecco P, Caratto E, Iiritano E, Fasciolo D, Bilardi C, Mansi C, Testa E, Savarino V. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther 2002; 16: 1291-1299 [PMID: 12144579]
10. Fox JG, Yan LL, Dewhirst FE, Paster BJ, Shames B, Murphy JC, Hayward A, Belcher JC, Mendes EN. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 1995; 33: 445-454 [PMID: 7536217]
11. Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 1996; 64: 3673-3681 [PMID: 8751916]
12. Franklin CL, Beckwith CS, Livingston RS, Riley LK, Gibson SV, Besch-Williford CL, Hook RR. Isolation of a novel Helicobacter species, Helicobacter cholecystus sp. nov., from the gallbladders of Syrian hamsters with cholangiofibrosis and centrilobular pancreatitis. J Clin Microbiol 1996; 34: 2952-2958 [PMID: 8940429]
13. Kawaguchi M, Saito T, Ohno H, Midorikawa S, Sanji T, Handa Y, Morita S, Yoshida H, Tsurui M, Misaka R, Hirota T, Saito M, Minami K. Bacteria closely resembling Helicobacter pylori detected immunohistologically and genetically in resected gallbladder mucosa. J Gastroenterol 1996; 31: 294-298 [PMID: 8680555]
14. Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadström T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38: 1072-1076 [PMID: 10698999]
15. Schmulson MJ, De León G, Kershenovich A, Vargas-Vorackova F, Kershenobich D. Helicobacter pylori infection among patients with alcoholic and nonalcoholic cirrhosis. Helicobacter 1997; 2: 149-151 [PMID: 9432344]
16. Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, Miglioli M, Corinaldesi R, Bolondi L. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997; 42: 2024-2030 [PMID: 9365129]
17. Fan XG, Zou YY, Wu AH, Li TG, Hu GL, Zhang Z. Seroprevalence of Helicobacter pylori infection in patients with hepatitis B. Br J Biomed Sci 1998; 55: 176-178 [PMID: 10367401]
18. Pellicano R, Leone N, Berrutti M, Cutufia MA, Fiorentino M, Rizzetto M, Ponzetto A. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol 2000; 33: 648-650 [PMID: 11059871]
19. Ponzetto A, Cutufia MA, D'Errico A, Angelino R, Pellicano R, Leone N. Demonstration of Helicobacter spp by PCR in liver of patients with liver cirrhosis and hepatocellular carcinoma. Gut 1999; 45: A88
20. Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, Mégraud F. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000; 89: 1431-1439 [PMID: 11013355]
21. Dore MP, Realdi G, Mura D, Graham DY, Sepulveda AR. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci 2002; 47: 1638-1643 [PMID: 12141829]
22. Rocha M, Avenaud P, Ménard A, Le Bail B, Balabaud C, Bioulac-Sage P, de Magalhães Queiroz DM, Mégraud F. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005; 54: 396-401 [PMID: 15710989]
23. Rabelo-Gonçalves EM, Sgardioli IC, Lopes-Cendes I, Escanhoela CA, Almeida JR, Zeitune JM. Improved detection of Helicobacter pylori DNA in formalin-fixed paraffin-embedded (FFPE) tissue of patients with hepatocellular carcinoma using laser capture microdissection (LCM). Helicobacter 2013; 18: 244-245 [PMID: 23350684 DOI: 10.1111/hel.12040]
24. de Magalhães Queiroz DM, Santos A. Isolation of a Helicobacter strain from the human liver. Gastroenterology 2001; 121: 1023-1024 [PMID: 11665691]
25. Xuan SY, Li N, Qiang X, Zhou RR, Shi YX, Jiang WJ. Helicobacter infection in hepatocellular carcinoma tissue. World J Gastroenterol 2006; 12: 2335-2340 [PMID: 16688821]
26. Manes G, Balzano A, Vaira D. Helicobacter pylori and pancreatic disease. JOP 2003; 4: 111-116 [PMID: 12743416]
27. Raderer M, Wrba F, Kornek G, Maca T, Koller DY, Weinlaender G, Hejna M, Scheithauer W. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998; 55: 16-19 [PMID: 9428370]
28. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, Virtamo J, Albanes D. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001; 93: 937-941 [PMID: 11416115 DOI: 10.1093/jnci/93.12.937]
29. Xiao M, Wang Y, Gao Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS One 2013; 8: e75559 [PMID: 24086571 DOI: 10.1371/journal.pone.0075559]
30. Wang Y, Zhang FC, Wang YJ. Helicobacter pylori and pancreatic cancer risk: a meta-analysis based on 2,049 cases and 2,861 controls. Asian Pac J Cancer Prev 2014; 15: 4449-4454 [PMID: 24969867]
31. Luo J, Nordenvall C, Nyrén O, Adami HO, Permert J, Ye W. The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease. Int J Cancer 2007; 120: 368-372 [PMID: 17044024 DOI: 10.1002/ijc.22123]
32. Bao Y, Spiegelman D, Li R, Giovannucci E, Fuchs CS, Michaud DS. History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterology 2010; 138: 541-549 [PMID: 19818786 DOI: 10.1053/j.gastro.2009.09.059]
33. Warzecha Z, Dembinski A, Ceranowicz P, Dembinski M, Sendur R, Pawlik WW, Konturek SJ. Deleterious effect of Helicobacter pylori infection on the course of acute pancreatitis in rats. Pancreatology 2002; 2: 386-395 [PMID: 12138227 DOI: 10.1159/000065086]
34. Niemann T, Larsen S, Mouritsen EA, Thorsgaard N. Helicobacter pylori infection in patients with chronic pancreatitis and duodenal ulcer. Scand J Gastroenterol 1997; 32: 1201-1203 [PMID: 9438316]
35. Manes G, Dominguez-Muñoz JE, Hackelsberger A, Leodolter A, Rössner A, Malfertheiner P. Prevalence of Helicobacter pylori infection and gastric mucosal abnormalities in chronic pancreatitis. Am J Gastroenterol 1998; 93: 1097-1100 [PMID: 9672337]
36. Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med 2005; 9: 196-207 [PMID: 15784177 DOI: 10.1111/j.1582-4934.2005.tb00349x]
37. Marietti M, Gasbarrini A, Saracco G, Pellicano R. Helicobacter pylori infection and diabetes mellitus: the 2013 state of art. Panminerva Med 2013; 55: 277-281 [PMID: 24088801]
38. Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A. Helicobacter pylori and extragastric diseases. Helicobacter 2014; 19 Suppl 1: 52-58 [PMID: 25167946 DOI: 10.1111/hel.12159]
39. Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011; 16: 79-88 [PMID: 21435084 DOI: 10.1111/j.1523-5378.2011.00822.x]
40. Franceschi F, Annalisa T, Teresa DR, Giovanna D, Ianiro G, Franco S, Viviana G, Valentina T, Riccardo LL, Antonio G. Role of Helicobacter pylori infection on nutrition and metabolism. World J Gastroenterol 2014; 20: 12809-12817 [PMID: 25278679 DOI: 10.3748/wjg.v20.i36.12809]
41. Malfertheiner P, Link A, Selgrad M. Helicobacter pylori: perspectives and time trends. Nat Rev Gastroenterol Hepatol 2014; 11: 628-638 [PMID: 25001975 DOI: 10.1038/nrgastro.2014.99]
42. Lau WY. Primary liver tumors. Semin Surg Oncol 2000; 19: 135-144 [PMID: 11126378]
43. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb 2002; 47: 389-399 [PMID: 11874260]
44. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917 [PMID: 14667750]
45. Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon 2005; 3: 210-215 [PMID: 16076007]
46. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078]
47. Tu QV, Okoli AS, Kovach Z, Mendz GL. Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp. Future Microbiol 2009; 4: 1283-1301 [PMID: 19995189 DOI: 10.2217/fmb.09.90]
48. Hall AJ, Wild CP. Liver cancer in low and middle income countries. BMJ 2003; 326: 994-995 [PMID: 12742895]
49. Pellicano R, Ménard A, Rizzetto M, Mégraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008; 8: 254-260 [PMID: 18353266 DOI: 10.1016/S1473-3099(08)70066-5]
50. Bosch FX, Ribes J, Cléries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191-211, v [PMID: 15831268]
51. Humpage AR, Falconer IR. Mycrocystin-LR and liver tumor promotion: effects on cytokinesis, ploidy, and apoptosis in cultured hepatocytes. Env Toxicol 1999; 14: 61-75
52. Liu CJ, Kao JH. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. J Chin Med Assoc 2007; 70: 141-145 [PMID: 17475593]
53. Farinati F, Cardin R, Bortolami M, Burra P, Russo FP, Rugge M, Guido M, Sergio A, Naccarato R. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat 2007; 14: 821-829 [PMID: 18070284]
54. Nilsson HO, Mulchandani R, Tranberg KG, Stenram U, Wadström T. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 2001; 120: 323-324 [PMID: 11246512]
55. Verhoef C, Pot RG, de Man RA, Zondervan PE, Kuipers EJ, IJzermans JN, Kusters JG. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2003; 15: 1171-1174 [PMID: 14560149]
56. Pellicano R, Mazzaferro V, Grigioni WF, Cutufia MA, Fagoonee S, Silengo L, Rizzetto M, Ponzetto A. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol 2004; 10: 598-601 [PMID: 14966925]
57. Pirouz T, Zounubi L, Keivani H, Rakhshani N, Hormazdi M. Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method. Dig Dis Sci 2009; 54: 1456-1459 [PMID: 18975076 DOI: 10.1007/s10620-008-0522-5]
58. Ponzetto A, Pellicano R, Leone N, Berrutti M, Turrini F, Rizzetto M. Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med 2000; 56: 206-210 [PMID: 10821975]
59. Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M, Silengo L. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 2000; 54: 275-277 [PMID: 10790764]
60. Spinzi G, Pellicano R, Minoli G, Terreni N, Cutufia MA, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Panminerva Med 2001; 43: 85-87 [PMID: 11449177]
61. Leone N, Pellicano R, Brunello F, Cutufia MA, Berrutti M, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev 2003; 27: 494-497 [PMID: 14642558]
62. Ponzetto A, Pellicano R, Redaelli A, Rizzetto M, Roffi L. Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseases. New Microbiol 2003; 26: 321-328 [PMID: 14596342]
63. Queiroz DM, Rocha AM, Rocha GA, Cinque SM, Oliveira AG, Godoy A, Tanno H. Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus. Dig Dis Sci 2006; 51: 370-373 [PMID: 16534683]
64. Tsuneyama K, Harada K, Kono N, Hiramatsu K, Zen Y, Sudo Y, Gershwin ME, Ikemoto M, Arai H, Nakanuma Y. Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis. J Hepatol 2001; 35: 156-163 [PMID: 11580136]
65. Leelawat K, Suksumek N, Leelawat S, Lek-Uthai U. Detection of VacA gene specific for Helicobactor pylori in hepatocellular carcinoma and cholangiocarcinoma specimens of Thai patients. Southeast Asian J Trop Med Public Health 2007; 38: 881-885 [PMID: 18041306]
66. Ito K, Nakamura M, Toda G, Negishi M, Torii A, Ohno T. Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 2004; 13: 221-227 [PMID: 14719127]
67. Abu Al-Soud W, Stenram U, Ljungh A, Tranberg KG, Nilsson HO, Wadström T. DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma. Dig Liver Dis 2008; 40: 126-131 [PMID: 18083084]
68. Ihrig M, Schrenzel MD, Fox JG. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 1999; 155: 571-582 [PMID: 10433949]
69. Taylor NS, Fox JG, Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol 1995; 42: 48-52 [PMID: 7739025]
70. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545 [PMID: 11229684]
71. Ito K, Yamaoka Y, Ota H, El-Zimaity H, Graham DY. Adherence, internalization, and persistence of Helicobacter pylori in hepatocytes. Dig Dis Sci 2008; 53: 2541-2549 [PMID: 18320323 DOI: 10.1007/s10620-007-0164-z]
72. Liu X, Liang J, Li G. Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15. Mol Biol Rep 2010; 37: 2235-2239 [PMID: 19680784 DOI: 10.1007/s11033-009-9710-4]
73. Huang Y, Fan XG, Zhou JH. [Immunohistochemistry of Helicobacter pylori in primary liver carcinoma tissues]. Zhongnan Daxue Xuebao Yixueban 2004; 29: 15-17 [PMID: 16136995]
74. Esmat G, El-Bendary M, Zakarya S, Ela MA, Zalata K. Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression. J Viral Hepat 2012; 19: 473-479 [PMID: 22676359 DOI: 10.1111/j.1365-2893.2011.01567.x]
75. Sathar SA, Kunnathuparambil SG, Sreesh S, Narayanan P, Vinayakumar KR. Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy. Ann Gastroenterol 2014; 27: 48-52 [PMID: 24714519]
76. Rabinovitz M, Yoo YK, Schade RR, Dindzans VJ, Van Thiel DH, Gavaler JS. Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci 1990; 35: 705-710 [PMID: 2344804]
77. Abdel-Hady H, Zaki A, Badra G, Lotfy M, Selmi C, Giorgini A, El-Sayed M, Badr R. Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007; 37: 1026-1033 [PMID: 17610507]
78. Schulz C, Schütte K, Malfertheiner P. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol 2014; 48: 491-499 [PMID: 24583758 DOI: 10.1097/MCG.0000000000000108]
79. Feng H, Zhou X, Zhang G. Association between cirrhosis and Helicobacter pylori infection: a meta-analysis. Eur J Gastroenterol Hepatol 2014; 26: 1309-1319 [PMID: 25304251 DOI: 10.1097/MEG0000000000000220]
80. Pellicano R, Fagoonee S. Helicobacter pylori and cirrhosis: any missing data in the meta-analysis? Eur J Gastroenterol Hepatol 2015; 27: 182-183 [PMID: 25533432 DOI: 10.097/MEG. 0000000000000243]
81. Floreani A, Biagini MR, Zappalà F, Farinati F, Plebani M, Rugge M, Surrenti C, Naccarato R. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a crosssectional study with matching. Ital J Gastroenterol Hepatol 1997; 29: 13-17 [PMID: 9265572]
82. Durazzo M, Rosina F, Premoli A, Morello E, Fagoonee S, Innarella R, Solerio E, Pellicano R, Rizzetto M. Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol 2004; 10: 3179-3181 [PMID: 15457568]
83. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-267 [PMID: 15554421]
84. Shimamoto C, Hirata I, Katsu K. Breath and blood ammonia in liver cirrhosis. Hepatogastroenterology 2000; 47: 443-445 [PMID: 10791209]
85. Demirtürk L, Yazgan Y, zci O, Ozel M, Togrol E, Gültepe M, Gürbüz AK, Yildirim S. The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics. Helicobacter 2001; 6: 325-330 [PMID: 11843965]
86. Nandakumar R, Naik AS, Pandit B, Kamat R, Bhatia SJ. Effect of Helicobacter pylori eradication on serum ammonia levels in patients with chronic liver disease. Indian J Gastroenterol 2003; 22: 221-223 [PMID: 15030034]
87. Miquel J, Barcena R, Boixeda D, Fernández J, SanRoman AL, Martín-de-Argila C, Ramosa F. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001; 13: 1067-1072 [PMID: 11564957]
88. Huber M, Rössle M, Siegerstetter V, Ochs A, Haag K, Kist M, Blum HE. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 2001; 48: 541-544 [PMID: 11379349]
89. Zullo A, Hassan C, Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol 2003; 37: 164-168 [PMID: 12869889]
90. Hu BL, Wang HY, Yang GY. Association of Helicobacter pylori infection with hepatic encephalopathy risk: a systematic review. Clin Res Hepatol Gastroenterol 2013; 37: 619-625 [PMID: 23830279 DOI: 10.1016/jclinre.2013.05.004]
91. Kountouras J, Zavos C, Deretzi G. Helicobacter pylori might contribute to persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9: 624; author reply 624-625 [PMID: 21334456 DOI: 10.1016/j.cgh.2011.02.011]
92. Kountouras J, Zavos C, Deretzi G, Vardaka E, Boziki M, Gavalas E, Kouklakis G, Katsinelos P, Venizelos I, Nikolaidou C, Polyzos SA, Giartza-Taxidou E. Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis. Hepatology 2013; 57: 1284 [PMID: 22745033 DOI: 10.1002/ hep.25926]
93. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48 Suppl 1: S104-S112 [PMID: 18304679 DOI: 10.16/jjhep.2008.01.009]
94. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161 [PMID: 20460905 DOI: 10.1159/000282080]
95. Bhala N, Jouness RI, Bugianesi E. Epidemiology and natural history of patients with NAFLD. Curr Pharm Des 2013; 19: 5169-5176 [PMID: 23394091]
96. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438 [PMID: 7382552]
97. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419 [PMID: 10348825]
98. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, Younossi ZM. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-238 [PMID: 19049831 DOI: 10.1016/j.cgh.2008.11.005]
99. Li M, Shen Z, Li YM. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. World J Gastroenterol 2013; 19: 7024-7031 [PMID: 24222944 DOI: 10.3748/wjg.v19. i41.7024]
100. Cindoruk M, Cirak MY, Unal S, Karakan T, Erkan G, Engin D, Dumlu S, Turet S. Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases. Eur J Gastroenterol Hepatol 2008; 20: 33-36 [PMID: 18090988 DOI: 10.197/MEG.0b013e3282efa4f2]
101. Abenavoli L, Milic N, Masarone M, Persico M. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. Med Hypotheses 2013; 81: 913-915 [PMID: 24011768 DOI: 10.1016/j.mehy.2013.08.011]
102. Polyzos SA, Kountouras J, Papatheodorou A, Patsiaoura K, Katsiki E, Zafeiriadou E, Zavos C, Anastasiadou K, Terpos E. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2013; 62: 121-126 [PMID: 22841522 DOI: 10.1016/jmetabol.2012.06.007]
103. Sumida Y, Kanemasa K, Imai S, Mori K, Tanaka S, Shimokobe H, Kitamura Y, Fukumoto K, Kakutani A, Ohno T, Taketani H, Seko Y, Ishiba H, Hara T, Okajima A, Yamaguchi K, Moriguchi M, Mitsuyoshi H, Yasui K, Minami M, Itoh Y. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol 2015; 50: 996-1004 [PMID: 25622927]
104. Goo MJ, Ki MR, Lee HR, Yang HJ, Yuan DW, Hong IH, Park JK, Hong KS, Han JY, Hwang OK, Kim DH, Do SH, Cohn RD, Jeong KS. Helicobacter pylori promotes hepatic fibrosis in the animal model. Lab Invest 2009; 89: 1291-1303 [PMID: 19736546 DOI: 10.138/labinvest.2009.90]
105. Ki MR, Goo MJ, Park JK, Hong IH, Ji AR, Han SY, You SY, Lee EM, Kim AY, Park SJ, Lee HJ, Kim SY, Jeong KS. Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-β1-induced inflammatory signaling. Lab Invest 2010; 90: 1507-1516 [PMID: 20531291 DOI: 10.138/labinvest.2010.109]
106. García-Trevijano ER, Iraburu MJ, Fontana L, Domínguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology 1999; 29: 960-970 [PMID: 10051504]
107. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gäbele E, Rusyn I, Yamashina S, Froh M, Adachi Y, Iimuro Y, Bradford BU, Smutney OM, Connor HD, Mason RP, Goyert SM, Peters JM, Gonzalez FJ, Samulski RJ, Thurman RG. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001; 31: 1544-1549 [PMID: 11744328]
108. Franceschi F, Zuccalà G, Roccarina D, Gasbarrini A. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol 2014; 11: 234-242 [PMID: 24345888 DOI: 10.1038/nrgastro.2013.243]
109. Imrie CW. Acute pancreatitis: overview. Eur J Gastroenterol Hepatol 1997; 9: 103-105 [PMID: 9058618]
110. Whitcomb DC. Clinical practice. Acute pancreatitis. N Engl J Med 2006; 354: 2142-2150 [PMID: 16707751 DOI: 10.1056/NEJMc054958]
111. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet 2008; 371: 143-152 [PMID: 18191686 DOI: 10.1016/S0140-6736(08)60107-5]
112. Chen TA, Lo GH, Lin CK, Lai KH, Wong HY, Yu HC, Hsu PI, Chen HH, Tsai WL, Chen WC. Acute pancreatitis-associated acute gastrointestinal mucosal lesions: incidence, characteristics, and clinical significance. J Clin Gastroenterol 2007; 41: 630-634 [PMID: 17577121 DOI: 10.1097/01.mcg.0000225638.37533.8c]
113. Lee KM, Paik CN, Chung WC, Yang JM. Association between acute pancreatitis and peptic ulcer disease. World J Gastroenterol 2011; 17: 1058-1062 [PMID: 21448359 DOI: 10.3748/wjg.v17j8.1058]
114. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007; 102: 2696-2707 [PMID: 17764494 DOI: 10.1111/j.1572-0241.2007.01510.x]
115. Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-1617 [PMID: 20427809 DOI: 10.1056/NEJMra0901557]
116. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis 2010; 28: 645-656 [PMID: 21088417 DOI: 10.1159/000320068]
117. Kang R, Tang D. Autophagy in pancreatic cancer pathogenesis and treatment. Am J Cancer Res 2012; 2: 383-396 [PMID: 22860230]
118. Lowenfels AB, Maisonneuve P, Lankisch PG. Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am 1999; 28: 673-685, x [PMID: 10503143]
119. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010; 24: 349-358 [PMID: 20510834 DOI: 10.1016/j.bpg.2010.02.007]
120. Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 2012; 23: 2964-2970 [PMID: 22767586 DOI: 10.1093/annonc/mds140]
121. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-1261 [PMID: 23622135 DOI: 10.1053/j.gastro.2013.01.068]
122. Tham TC, Chen L, Dennison N, Johnston CF, Collins JS, Ardill JE, Buchanan KD. Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans. Eur J Gastroenterol Hepatol 1998; 10: 289-291 [PMID: 9855043]
123. Park SM, Lee HR, Kim JG, Park JW, Jung G, Han SH, Cho JH, Kim MK. Effect of Helicobacter pylori infection on antral gastrin and somatostatin cells and on serum gastrin concentrations. Korean J Intern Med 1999; 14: 15-20 [PMID: 10063309]
124. Larsson LI. Developmental biology of gastrin and somatostatin cells in the antropyloric mucosa of the stomach. Microsc Res Tech 2000; 48: 272-281 [PMID: 10700044 DOI: 10.1002/(SICI)1097-0029]
125. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003; 95: 948-960 [PMID: 12837831 DOI: 10.1093/jnci/95.13.948]
126. Trikudanathan G, Philip A, Dasanu CA, Baker WL. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP 2011; 12: 26-31 [PMID: 21206097]
127. Dobrila-Dintinjana R, Vanis N, Dintinjana M, Radic M. Etiology and oncogenesis of pancreatic carcinoma. Coll Antropol 2012; 36: 1063-1067 [PMID: 23213974]
128. Nilsson HO, Stenram U, Ihse I, Wadstrom T. Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. World J Gastroenterol 2006; 12: 3038-3043 [PMID: 16718784 DOI: 10.3748/wjg.v12.i19.3038]
129. Takayama S, Takahashi H, Matsuo Y, Okada Y, Manabe T. Effects of Helicobacter pylori infection on human pancreatic cancer cell line. Hepatogastroenterology 2007; 54: 2387-2391 [PMID: 18265671]
130. Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis 2013; 34: 2193-2197 [PMID: 23843038 DOI: 10.1093/carcin/bgt249]
131. Lindkvist B, Johansen D, Borgström A, Manjer J. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer 2008; 8: 321 [PMID: 18986545 DOI: 10.1186/1471-2407-8-321]
132. Ai F, Hua X, Liu Y, Lin J, Feng Z. Preliminary study of pancreatic cancer associated with Helicobacter pylori infection. Cell Biochem Biophys 2015; 71: 397-400 [PMID: DOI: 10.1007/s12013-014-021 1-2]
133. Fan BG, Andrén-Sandberg A. Autoimmune pancreatitis. N Am J Med Sci 2009; 1: 148-151 [PMID: 22666688]
134. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002; 51: 1-4 [PMID: 12077078 DOI: 10.1136/gut51.1.1]
135. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99: 1605-1616 [PMID: 15307882 DOI: 10.1111/j.1572-0241.2004.30336x]
136. Shinji A, Sano K, Hamano H, Unno H, Fukushima M, Nakamura N, Akamatsu T, Kawa S, Kiyosawa K. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc 2004; 59: 506-511 [PMID: 15044886 DOI: 10.1016/S0016-5107(03)02874-8]
137. Persidis A. Autoimmune disease drug discovery. Nat Biotechnol 1999; 17: 1038 [PMID: 10504714 DOI: 10.1038/13748]
138. Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid 2004; 14: 964-966 [PMID: 15671776 DOI: 10.1089/thy.2004.14.964]
139. Spechler SJ. Peptic ulcer disease and its complications. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 7th ed. Philadelphia, PA: Saunders, 2002: 747-781
140. Kountouras J, Zavos C, Chatzopoulos D. Autoimmune pancreatitis, Helicobacter pylori infection and apoptosis: a proposed relationship. Pancreas 2005; 30: 192-193
141. Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 2005; 9: 741-744 [PMID: 16202223 DOI: 10.1111/j.1582-4934.2005.tb00506x]
142. Klöppel G, Lüttges J, Löhr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 2003; 27: 14-19 [PMID: 12826900]
143. Chirica LC, Petersson C, Hurtig M, Jonsson BH, Borén T, Lindskog S. Expression and localization of alpha-and betacarbonic anhydrase in Helicobacter pylori. Biochim Biophys Acta 2002; 1601: 192-199 [PMID: 12445482]
144. Marcus EA, Moshfegh AP, Sachs G, Scott DR. The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation. J Bacteriol 2005; 187: 729-738 [PMID: 15629943]
145. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmunerelated pancreatitis. J Gastroenterol 2001; 36: 293-302 [PMID: 11388391 DOI: 10.1007/s005350170094]
146. DiMagno EP, Chari S. Acute pancreatitis. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th Ed. Philadelphia, PA: Saunders, 2002: 913-941
147. Kountouras J, Zavos C, Chatzopoulos D. Induction of apoptosis as a proposed pathophysiological link between glaucoma and Helicobacter pylori infection. Med Hypotheses 2004; 62: 378-381 [PMID: 14975507]
148. Zhou X, Zhang C, Wu J, Zhang G. Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. Diabetes Res Clin Pract 2013; 99: 200-208 [PMID: 23395214 DOI: 10.1016/j.diabres.2012.11.012]
149. Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, Aiello AE. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012; 35: 520-525 [PMID: 22279028 DOI: 10.2337/dc11-1043]
150. Albaker WI. Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact? Saudi J Gastroenterol 2011; 17: 165-169 [PMID: 21546717 DOI: 10.4103/1319-3767.80377]
151. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009; 14: 144-150 [PMID: 19751440 DOI: 10.1111/j.1523-5378.2009.00705.x]
152. So WY, Tong PC, Ko GT, Ma RC, Ozaki R, Kong AP, Yang X, Ho CS, Lam CC, Chan JC. Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res Clin Pract 2009; 86: 89-95 [PMID: 19747747 DOI: 10.1016/j.diabres.2009.08.010]
153. Shin DW, Kwon HT, Kang JM, Park JH, Choi HC, Park MS, Park SM, Son KY, Cho B. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol 2012; 46: 840-845 [PMID: 23064216 DOI: 10.1097/MCG.0b013e3182522477]
154. Banic M, Franceschi F, Babic Z, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2012; 17 Suppl 1: 49-55 [PMID: 22958156]
155. Malfertheiner P, Selgrad M, Bornschein J. Helicobacter pylori: clinical management. Curr Opin Gastroenterol 2012; 28: 608-614 [PMID: 23010682 DOI: 10.1097/MOG.0b013e32835918a7]